Evidence map›Paper›PMID 23085908›Full record

ArticleJournal of biomedical optics2012

Optical mapping at increased illumination intensities.

Giedrius Kanaporis, Irma Martišienė, Jonas Jurevičius, Rūta Vosyliūtė, Antanas Navalinskas, Rimantas Treinys, Arvydas Matiukas, Arkady M Pertsov

Abstract readComparative Study
In one paragraph

Article in Journal of biomedical optics, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Giedrius KanaporisLithuanian University of Health Sciences, Institute of Cardiology, Laboratory of Membrane Biophysics, 17 Sukileliu pr, Kaunas 50161, Lithuania.
Irma Martišienė
Jonas Jurevičius
Rūta Vosyliūtė
Antanas Navalinskas
Rimantas Treinys
Arvydas Matiukas
Arkady M Pertsov

Funding

Depth-resolved imaging of myocardial excitationR01HL071762 · NHLBI · UPSTATE MEDICAL UNIVERSITY · PI PERTSOV, ARKADY M · 2003 to 2011
$2.1M
Development of new NIR probes to study human cardiac excitationR03TW008039 · FIC · UPSTATE MEDICAL UNIVERSITY · PI PERTSOV, ARKADY M · 2009 to 2011
$106k
FIC NIH HHS R03 TW008039FIC NIH HHS R03 TW008039-03NHLBI NIH HHS R01 HL071762NHLBI NIH HHS R01 HL 071762-05
6 · The paper itself

Abstract

Voltage-sensitive fluorescent dyes have become a major tool in cardiac and neuro-electrophysiology. Achieving high signal-to-noise ratios requires increased illumination intensities, which may cause photobleaching and phototoxicity. The optimal range of illumination intensities varies for different dyes and must be evaluated individually. We evaluate two dyes: di-4-ANBDQBS (excitation 660 nm) and di-4-ANEPPS (excitation 532 nm) in the guinea pig heart. The light intensity varies from 0.1 to 5  mW/mm2, with the upper limit at 5 to 10 times above values reported in the literature. The duration of illumination was 60 s, which in guinea pigs corresponds to 300 beats at a normal heart rate. Within the identified duration and intensity range, neither dye shows significant photobleaching or detectable phototoxic effects. However, light absorption at higher intensities causes noticeable tissue heating, which affects the electrophysiological parameters. The most pronounced effect is a shortening of the action potential duration, which, in the case of 532-nm excitation, can reach ∼30%. At 660-nm excitation, the effect is ∼10%. These findings may have important implications for the design of optical mapping protocols in biomedical applications.

Indexed as

Pyridinium CompoundsQuinolinium Compounds2-NaphthylamineAction PotentialsAnimalsBody Surface Potential MappingFluorescent DyesHeart Conduction SystemReproducibility of ResultsSensitivity and SpecificitySwineVoltage-Sensitive Dye Imaging1-(3-sulfonatopropyl)-4-(beta)(2-(di-n-butylamino)-6-naphthylvinyl)pyridinium betaine1-(4-sulfanatobutyl)-4-(beta-(2-(di-n-butylamino)-6-naphthyl)butadienyl)quinolinium betaine2-NaphthylamineFluorescent DyesPyridinium CompoundsQuinolinium Compounds

Identifiers

PMID23085908
PMCPMC3602814

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.